Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype

We have investigated the extent and pattern of immunostaining for ubiquitin protein (UBQ) in 60 patients with frontotemporal lobar degeneration (FTLD) with ubiquitin-positive, tau-negative inclusions (FTLD-U), 37 of whom were ascertained in Manchester UK and 23 in Newcastle-Upon-Tyne, UK. There were three distinct histological patterns according to the form and distribution of the UBQ pathology. Histological type 1 was present in 19 patients (32%) and characterised by the presence of a moderate number, or numerous, UBQ immunoreactive neurites and intraneuronal cytoplasmic inclusions within layer II of the frontal and temporal cerebral cortex, and cytoplasmic inclusions within granule cells of the dentate gyrus; neuronal intranuclear inclusions (NII) of a “cat’s eye” or “lentiform” appearance were present in 17 of these patients. In histological type 2 (16 patients, 27%), UBQ neurites were predominantly, or exclusively, present with few intraneuronal cytoplasmic inclusions within layer II of the cerebral cortex, while in histological type 3 (25 patients, 42%), UBQ intraneuronal cytoplasmic inclusions either within the cortical layer II or in the granule cells of the dentate gyrus, with few or no UBQ neurites, were seen. In neither of these latter two groups were NII present. The influence of histological type on clinical phenotype was highly significant with type 1 histology being associated clinically with cases of frontotemporal dementia (FTD) or progressive non-fluent aphasia (PNFA), type 2 histology with semantic dementia (SD), and type 3 histology with FTD, or FTD and motor neurone disease (MND).

[1]  Jennifer Farmer,et al.  Frontotemporal dementia: Clinicopathological correlations , 2006, Annals of neurology.

[2]  C. Duijn,et al.  Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval , 2002, Molecular Psychiatry.

[3]  J. Hodges,et al.  Clinicopathological correlates in frontotemporal dementia , 2004, Annals of neurology.

[4]  M. Bergmann,et al.  Different variants of frontotemporal dementia: a neuropathological and immunohistochemical study , 1996, Acta Neuropathologica.

[5]  D. Dickson,et al.  Ubiquitin Immunohistochemistry of Frontotemporal Lobar Degeneration Differentiates Cases With and Without Motor Neuron Disease , 2005, Alzheimer disease and associated disorders.

[6]  P. Talbot Frontal lobe dementia and motor neuron disease. , 1996, Journal of neural transmission. Supplementum.

[7]  D. Neary,et al.  Dementia lacking distinctive histology (DLDH) revisited , 2006, Acta Neuropathologica.

[8]  H. Feldman,et al.  The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease , 2003, Acta Neuropathologica.

[9]  Jing Shi,et al.  Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation , 2005, Acta Neuropathologica.

[10]  Mann Dma. The genetics and molecular pathology of frontotemporal lobar degeneration. , 2005 .

[11]  John R. Hodges,et al.  Fronto-Temporal Lobar Degeneration: Fronto-Temporal Dementia, Progressive Aphasia, Semantic Dementia. , 1997 .

[12]  J. Hodges,et al.  Survival in frontotemporal dementia , 2003, Neurology.

[13]  C. Duijn,et al.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.

[14]  Joseph James Duffy,et al.  Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP , 2006, Neurology.

[15]  S. Melquist,et al.  A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. , 2006, Brain : a journal of neurology.

[16]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[17]  L. Lannfelt,et al.  Extended investigation of tau and mutation screening of other candidate genes on chromosome 17q21 in a Swedish FTDP‐17 family , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[18]  Julie S. Snowden,et al.  Fronto-Temporal Lobar Degeneration: Fronto-Temporal Dementia, Progressive Aphasia, Semantic Dementia , 1996 .

[19]  D. Mann,et al.  The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein , 2004, Neuropathology and applied neurobiology.

[20]  M. Mesulam,et al.  Neuronal Ubiquitinated Intranuclear Inclusions in Familial and Non‐Familial Frontotemporal Dementia of the Motor Neuron Disease Type Associated with Amyotrophic Lateral Sclerosis , 2004, Journal of neuropathology and experimental neurology.

[21]  D. Neary,et al.  Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia , 1992, Neuroscience Letters.

[22]  K. Fliessbach,et al.  Mutant valosin‐containing protein causes a novel type of frontotemporal dementia , 2005, Annals of neurology.

[23]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[24]  D. Neary,et al.  Frontal lobe dementia and motor neuron disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[25]  Andrew Kertesz,et al.  Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions , 2001, Acta Neuropathologica.

[26]  J. Trojanowski,et al.  Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias. , 2005, Journal of neuropathology and experimental neurology.

[27]  M N Rossor,et al.  Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. , 2000, Brain : a journal of neurology.

[28]  M N Rossor,et al.  Frontotemporal lobar degeneration and ubiquitin immunohistochemistry , 2004, Neuropathology and applied neurobiology.

[29]  E. Bigio,et al.  Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration , 2004, Acta Neuropathologica.

[30]  W. Kamphorst,et al.  Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. , 2001, Brain : a journal of neurology.

[31]  C. Bouras,et al.  Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study , 2004, Acta Neuropathologica.

[32]  Charles D. Smith,et al.  Novel Ubiquitin Neuropathology in Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations , 2006, Journal of neuropathology and experimental neurology.